Skip to the content

Menu

Statement following NHS England’s announcement to provide glucose monitors for type 1 diabetes patients

NHS England has recently announced that wearable glucose monitoring technology will be funded for people with Type 1 diabetes from 1 April 2019. This will come from next year’s funding growth for local health groups, which will allow access to flash monitoring throughout the country.

In September 2018, Berkshire West CCG approved an evaluation study to analyse the impact of Freestyle Libre on patient outcomes. This study is currently taking place at the Royal Berkshire NHS Foundation Trust.

Over the coming months, we will be awaiting further information from NHS England around implementation and having discussions with our providers about how the devices will be made available. The CCG will also need to include the provision of Freestyle Libre monitors in its financial plans for 2019/20.

The CCG’s current Freestyle Libre policy is available here. This will be reviewed and updated in line with the NHS England announcement.

Further information about NHS England’s announcement can be found here.

If you need medical help and are unsure what to do, call NHS 111 for help and advice. They are available 24 hours a day.